Articles by Jill Wechsler - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jill Wechsler

New NIH Leader Backs Personalized Medicine

Jul 22, 2009

Collins seeks to parlay genomic discoveries into new biomedical therapies. Comparative effectiveness research, he says, should identify subpopulation responses to treatment and support personalized medicine.

Safety and Security

Jul 1, 2009

As FDA looks to balance risks and benefits, more regulations are on the horizon.

A Bigger, Bolder Agency

Jun 1, 2009

FDA is seeking more resources to support compliance and oversight.

Wrangling Over Research Results

May 21, 2009

Marketers fear a Catch-22 if they have to write research summaries that FDA considers illegal promotion.

Compared to What?

May 1, 2009

Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.

Kickoff for Reform

Apr 1, 2009

In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.

Through the Looking Glass

Mar 1, 2009

The latest buzzword in pharma is "transparency"

Securing Savings

Feb 1, 2009

A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.

FDA Turnaround Time

Jan 1, 2009

Will more resourches and new leadership fix FDA, or is a major overhaul in order?

ADVERTISEMENT

Click here